Sort
50,496 grants matching “lung cancer”
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
$1,951,504Stephen S Hecht · University Of Minnesota · P01 · FY2010 · CA
Center for Biomedical Engineering Technology Acceleration (BETA Center)
$1,951,275Manu Platt · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2025 · EB
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
$1,951,087Stephen S Hecht · University Of Minnesota · P01 · FY2020 · CA
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
$1,950,855Stephen S Hecht · University Of Minnesota · P01 · FY2014 · CA
Regulation Of Intracellular Iron Metabolism
$1,948,600Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Cancer Risk and Environmental Exposures
$1,948,414Mary H Ward · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Brain Tumor Clinical and Clinical Research Program (Clinical Support Services)
$1,948,127Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
Molecular Mechanism of Action of Phorbol Ester
$1,946,385Peter Blumberg · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
microRNA-based novel molecular therapeutics in thoracic cancers
$1,944,239Chuong Hoang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$1,943,482John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
$1,943,218Joseph J Cullen · University Of Iowa · P01 · FY2021 · CA
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
$1,943,218Joseph J Cullen · University Of Iowa · P01 · FY2020 · CA
GENERAL CLINICAL RESEARCH CENTER
$1,940,372University Of Colorado Denver · M01 · FY2002 · RR
Comparative Modeling of Lung Cancer Control Policies
$1,939,959Pamela Markell McMahon · Massachusetts General Hospital · U01 · FY2011 · CA
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
$1,939,848Joseph J Cullen · University Of Iowa · P01 · FY2018 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,939,404Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2013 · CA
Transgenic Models for Prostate and Breast Cancer
$1,938,182Jeffrey E Green · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$1,938,066Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
NHLBI Transgenic Core
$1,937,984Chengyu Liu · National Heart, Lung, And Blood Institute · ZIC · FY2016 · HL
BEdside Exclusion of Pulmonary Embolism in children without Radiation (BEEPER)
$1,937,790Jeffrey A Kline · Indiana University Indianapolis · R01 · FY2020 · HL
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
$1,936,770Debra L Friedman · Vanderbilt University Medical Center · UH3 · FY2023 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial
$1,935,456Barbara B O'Brien · Westat, Inc. · N01 · FY2013 · CA
Northwestern Cancer Prevention Consortium
$1,935,399Seema Ahsan Khan · Northwestern University At Chicago · UG1 · FY2023 · CA
DCTD In Vivo Preclinical Testing
$1,933,191David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Cancer Risk in Human Populations
$1,931,840Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA